Céleste Pinard (Hugo Veyssière, Hugo Veyssiere)

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 5

Top Topics

Single Molecule

Advanced Non Small Cell Lung Cancer

Top Venues

OncoTargets and therapy

This page only lists publications with an associated author ORCID identifier.

Publications

Hugo Veyssiere, Margot Dressaire, Raphaël Pete, Céleste Pinard, Ioana Molnar, Catherine Abrial, Angeline Ginzac, Xavier Durando, Marielle Tekath
RFID trial: localization of non-palpable breast lesions using radiofrequency identification tags or wire. BMC cancer 23 (1) (2023)
Brice Leyrat, Xavier Durando, Céleste Pinard, Maureen Bernadach
Durable Response to Crizotinib in a Patient with Pulmonary Adenocarcinoma Harboring MET Intron 14 Mutation: A Case Report. OncoTargets and therapy 14 (2021)
Céleste Pinard, Judith Passildas, Angeline Ginzac, Sejdi Lusho, Yannick Bidet, Ioana Molnar, Maureen Bernadach, Mathias Cavaille, Nina Radosevic-Robin, Xavier Durando
XENOBREAST Trial: A prospective study of xenografts establishment from surgical specimens of patients with triple negative or luminal b breast cancer. F1000Research 9 (2020)
Céleste Pinard, Judith Passildas, Angeline Ginzac, Sejdi Lusho, Yannick Bidet, Ioana Molnar, Maureen Bernadach, Mathias Cavaille, Nina Radosevic-Robin, Xavier Durando
XENOBREAST Trial: A prospective study of xenografts establishment from surgical specimens of patients with triple negative or luminal b breast cancer. F1000Research 9 (2020)
Céleste Pinard, Judith Passildas, Angeline Ginzac, Sejdi Lusho, Yannick Bidet, Ioana Molnar, Maureen Bernadach, Mathias Cavaille, Nina Radosevic-Robin, Xavier Durando
XENOBREAST Trial: A prospective study of xenografts establishment from surgical specimens of patients with triple negative or luminal b breast cancer. F1000Research 9 (2020)